Akebia Therapeutics: Q3 Earnings Snapshot
In This Article:
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $20 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 10 cents per share.
The kidney disease treatment developer posted revenue of $37.4 million in the period.
The company's shares closed at $2. A year ago, they were trading at $1.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA
Terms and Privacy Policy